Cargando…
P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india
POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Due to the coronavirus disease (COVID-19) pandemic, a rapid increase in the number of opportunistic fungal infections was observed worldwide. Cases of mucormycosis described in patients with COVID-19 have been termed as COVID-19...
Autores principales: | Sengupta, Arupparna, Misra, Sunayana, Dhawan, Shashi, Badwal, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515863/ http://dx.doi.org/10.1093/mmy/myac072.P338 |
Ejemplares similares
-
P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India
por: Sharad, Neha, et al.
Publicado: (2022) -
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India
por: Yadav, Sukriti, et al.
Publicado: (2022) -
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India
por: Marak, Rungmei S K, et al.
Publicado: (2022) -
P295 Overview of post-covid mucormycosis in a tertiary care hospital in South India
por: Sridhar, Kripa
Publicado: (2022) -
P186 Disseminated Histoplasmosis in an immunocompetent patient in a tertiary care center in North India
por: Dubey, Akanksha, et al.
Publicado: (2022)